Analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
MediciNova Trading Up 4.2 %
MediciNova stock opened at $1.24 on Monday. The business’s 50 day simple moving average is $1.32 and its 200 day simple moving average is $1.36. MediciNova has a 12 month low of $1.12 and a 12 month high of $2.49. The company has a market cap of $60.82 million, a price-to-earnings ratio of -7.29 and a beta of 0.72.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in MediciNova stock. Bank Julius Baer & Co. Ltd Zurich acquired a new stake in shares of MediciNova, Inc. (NASDAQ:MNOV – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 19,000 shares of the biopharmaceutical company’s stock, valued at approximately $28,000. Institutional investors own 9.90% of the company’s stock.
About MediciNova
MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID.
Further Reading
- Five stocks we like better than MediciNova
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- How to Calculate Options Profits
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Industrial Products Stocks Investing
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for MediciNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediciNova and related companies with MarketBeat.com's FREE daily email newsletter.